The Food and Drug Administration yesterday issued guidance allowing patients to use certain non-invasive fetal and maternal monitoring devices in the home during the COVID-19 emergency to reduce the need for in-clinic visits. FDA also issued guidance to expand mobile and portable imaging options to diagnose and monitor treatment of lung disease patients with COVID-19 during the emergency.

Related News Articles

Headline
The Health Resources and Services Administration today awarded 14 organizations grants to hire people to support COVID-19 vaccination and outreach in…
Headline
The Food and Drug Administration Friday authorized for emergency use two batches of drug substance manufactured for the Janssen (Johnson & Johnson)…
Headline
Novavax today announced phase 3 trial results for its COVID-19 vaccine, saying it provides 100% protection against moderate and severe disease, with a 90.…
Headline
The Food and Drug Administration yesterday warned health care providers and the public not to use an antigen test for COVID-19 made by Innova Medical Group and…
Headline
The Health Resources and Services Administration today awarded $100,000 each to more than 4,200 rural health clinics to maintain and increase COVID-19 testing…
Headline
The Centers for Disease Control and Prevention is asking jurisdictions to distribute portions of their COVID-19 vaccine allocations to enable administration at…